Robert J. Bertolini

President, Chief Financial Officer at Bausch & Lomb Holdings, Inc.

Robert J. Bertolini

Robert J. Bertolini

President, Chief Financial Officer at Bausch & Lomb Holdings, Inc.

Overview
Career Highlights

Schering-Plough Corporation
Merck & Co., Inc.
Schering Plough Products LLC

RelSci Relationships

10306

Number of Boards

11

Birthday

12/1961

Age

57

Number of Awards

1

Relationships
RelSci Relationships are individuals Robert J. Bertolini likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Charles River Laboratories, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Idorsia Ltd.

Relationship likelihood: Strong

Professional at Jabil, Inc.

Relationship likelihood: Strong

Operating Partner at Advent International Corp.

Relationship likelihood: Strong

Professional at Charles River Laboratories, Inc.

Relationship likelihood: Strong

Professional at Breakaway Solutions, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at PostNL NV

Relationship likelihood: Strong

Provost & Senior Vice President Ad Interim at Tufts University

Relationship likelihood: Strong

Professional at Cerner Corporation

Relationship likelihood: Strong

Paths to Robert J. Bertolini
Potential Connections via
Relationship Science
You
Robert J. Bertolini
President, Chief Financial Officer at Bausch & Lomb Holdings, Inc.
Education
Bachelor's Degree in Economics

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

Career History
President, Chief Financial Officer
2013 - Current

Bausch & Lomb Holdings, Inc. develops, manufactures, and markets eye health products. Its products include contact lenses, contact lens care solutions, ophthalmic pharmaceuticals, and surgical products. The company was founded on September 25, 2009 and is headquartered in Rochester, NY.

Professional
2011 - Current

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Professional
2009 - Current

Genzyme Corp. develops and manufactures specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Boards & Committees
Member, Board of Directors
2017 - Current

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Member, Board of Directors
2010 - Current

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Non-Executive Director
Current

Idorsia Ltd. is a biopharmaceutical company. It engages in the discovery and development of small molecules used for therapeutic products. The company focuses on diseases such as hypertension, systemic lupus erythematosus, chronic insomnia, Aneurysmal subarachnoid hemorrhage and fabry disease. Idorsia was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.

Director
Prior

New Jersey Performing Arts Center (NJPAC), located in downtown Newark, New Jersey, is among the largest performing arts centers in the United States and is the artistic, cultural, educational and civic center of New Jersey; where great performances and events enhance and transform lives every day. As New Jersey’s Town Square, NJPAC brings diverse communities together, providing access to all and showcasing the State’s and the world’s best artists while acting as a leading catalyst in the revitalization of its home city.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert J. Bertolini. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert J. Bertolini's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert J. Bertolini.